MicroRNAs define distinct human neuroblastoma cell phenotypes and regulate their differentiation and tumorigenicity

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Samaraweera, Leleesha ^a   Grandinetti, Kathryn B ^b   Huang, Ruojun ^c   Spengler, Barbara A ^d   Ross, Robert A ^d  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION   (United States)

^c Fordham University ^*

^d FORDHAM UNIVERSITY   (United States)

Author keywords

Differentiation; HuD; MicroRNAs; miR 124; miR 375; N myc; Neuroblastoma; Tumorigenicity

Indexed keywords

HAND1 PROTEIN; HUD PROTEIN; JAGGED1; MICRORNA; MICRORNA 124; MICRORNA 21; MICRORNA 221; MICRORNA 335; MICRORNA 375; MYC PROTEIN; REGULATOR PROTEIN; RNA BINDING PROTEIN; UNCLASSIFIED DRUG; ELAVL4 PROTEIN, HUMAN; HU ANTIGEN;

ARTICLE; CANCER STEM CELL; CARCINOGENICITY; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; NERVE CELL DIFFERENTIATION; NEUROBLAST; NEUROBLASTOMA CELL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; BRAIN TUMOR; CARCINOGENESIS; CHILD; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MICROARRAY ANALYSIS; NEURAL STEM CELL; NEUROBLASTOMA; PATHOLOGY; PHENOTYPE; TUMOR CELL LINE;

BRAIN NEOPLASMS; CARCINOGENESIS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CHILD; GENE EXPRESSION REGULATION, NEOPLASTIC; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS; HUMANS; MICROARRAY ANALYSIS; MICRORNAS; NEURAL STEM CELLS; NEUROBLASTOMA; PHENOTYPE; RNA-BINDING PROTEINS;

EID: 84901644445     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-309     Document Type: Article

References (31)

1. Park JR, Bagatell R, London WB, Maris JM, Cohn SL, Mattay KM, Hogarty M, Committee COGN. Children's Oncology Group's 2013 blueprint for research: neuroblastoma. Pediatric Blood Cancer 2013, 60(6):985-993.
2. Ross RA, Spengler BA. Human neuroblastoma stem cells. Semin Cancer Biol 2007, 17(3):241-247.
3. Spengler BA, Lazarova DL, Ross RA, Biedler JL. Cell lineage and differentiation state are primary determinants of MYCN gene expression and malignant potential in human neuroblastoma cells. Oncol Res 1997, 9(9):467-476.
4. Walton JD, Kattan DR, Thomas SK, Spengler BA, Guo HF, Biedler JL, Cheung NK, Ross RA. Characteristics of stem cells from human neuroblastoma cell lines and in tumors. Neoplasia 2004, 6(6):838-845.
5. Shimada H, Chatten J, Newton WA, Sachs N, Hamoudi AB, Chiba T, Marsden HB, Misugi K. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 1984, 73(2):405-416.
6. Eggert A, Schulte JH. A small kiss of death for cancer. Nat Med 2010, 16(10):1079-1081.
7. Stallings RL. MicroRNA involvement in the pathogenesis of neuroblastoma: potential for microRNA mediated therapeutics. Curr Pharm Des 2009, 15(4):456-462.
8. Stallings RL, Foley NH, Bryan K, Buckley PG, Bray I. Therapeutic targeting of miRNAs in neuroblastoma. Expert Opin Ther Targets 2010, 14(9):951-962.
9. Stallings RL, Foley NH, Bray IM, Das S, Buckley PG. MicroRNA and DNA methylation alterations mediating retinoic acid induced neuroblastoma cell differentiation. Semin Cancer Biol 2011, 21(4):283-290.
10. Ikegaki N, Bukovsky J, Kennett RH. Identification and characterization of the NMYC gene product in human neuroblastoma cells by monoclonal antibodies with defined specificities. Proc Natl Acad Sci U S A 1986, 83(16):5929-5933.
11. Thomas SK, Messam CA, Spengler BA, Biedler JL, Ross RA. Nestin is a potential mediator of malignancy in human neuroblastoma cells. J Biol Chem 2004, 279(27):27994-27999.
12. Schulte JH, Horn S, Otto T, Samans B, Heukamp LC, Eilers UC, Krause M, Astrahantseff K, Klein-Hitpass L, Buettner R, Schramm A, Christiansen H, Eilers M, Eggert A, Berwanger B. MYCN regulates oncogenic MicroRNAs in neuroblastoma. Int J Cancer 2008, 122(3):699-704.
13. Lin RJ, Lin YC, Chen J, Kuo HH, Chen YY, Diccianni MB, London WB, Chang CH, Yu AL. microRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastoma. Cancer Res 2010, 70(20):7841-7850.
14. Howard M, Foster DN, Cserjesi P. Expression of HAND gene products may be sufficient for the differentiation of avian neural crest-derived cells into catecholaminergic neurons in culture. Dev Biol 1999, 215(1):62-77.
15. Louvi A, Artavanis-Tsakonas S. Notch signalling in vertebrate neural development. Nature Rev Neurosci 2006, 7(2):93-102.
16. Liu XS, Chopp M, Zhang RL, Tao T, Wang XL, Kassis H, Hozeska-Solgot A, Zhang L, Chen C, Zhang ZG. MicroRNA profiling in subventricular zone after stroke: MiR-124a regulates proliferation of neural progenitor cells through Notch signaling pathway. PloS one 2011, 6(8):e23461.
17. Guo J, Dong Q, Fang Z, Chen X, Lu H, Wang K, Yin Y, Cai X, Zhao N, Chen J, Zen K, Zhang J, Zhang CY. Identification of miRNAs that are associated with tumor metastasis in neuroblastoma. Cancer Biol Ther 2010, 9(6):446-452.
18. Lynch J, Fay J, Meehan M, Bryan K, Watters KM, Murphy DM, Stallings RL. MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-beta signalling pathway. Carcinogenesis 2012, 33(5):976-985.
19. Bray I, Bryan K, Prenter S, Buckley PG, Foley NH, Murphy DM, Alcock L, Mestdagh P, Vandesompele J, Speleman F, London WB, McGrady PW, Higgins DG, O'Meara A, O'Sullivan M, Stallings RL. Widespread dysregulation of MiRNAs by MYCN amplification and chromosomal imbalances in neuroblastoma: association of miRNA expression with survival. PLoS One 2009, 4(11):e7850.
20. Chen Y, Stallings RL. Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis. Cancer Res 2007, 67(3):976-983.
21. Conaco C, Otto S, Han JJ, Mandel G. Reciprocal actions of REST and a microRNA promote neuronal identity. Proc Natl Acad Sci U S A 2006, 103(7):2422-2427.
22. Krichevsky AM, Sonntag KC, Isacson O, Kosik KS. Specific microRNAs modulate embryonic stem cell-derived neurogenesis. Stem Cells 2006, 24(4):857-864.
23. Mouillet-Richard S, Mutel V, Loric S, Tournois C, Launay JM, Kellermann O. Regulation by neurotransmitter receptors of serotonergic or catecholaminergic neuronal cell differentiation. J Biol Chem 2000, 275(13):9186-9192.
24. Thiele CJ, Reynolds CP, Israel MA. Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma. Nature 1985, 313(6001):404-406.
25. Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, Ramsay NK, Swift P, Shimada H, Black CT, Brodeur GM, Gerbing RB, Reynolds CP. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med 1999, 341(16):1165-1173.
26. Le MT, Xie H, Zhou B, Chia PH, Rizk P, Um M, Udolph G, Yang H, Lim B, Lodish HF. MicroRNA-125b promotes neuronal differentiation in human cells by repressing multiple targets. Mol Cell Biol 2009, 29(19):5290-5305.
27. Avnit-Sagi T, Kantorovich L, Kredo-Russo S, Hornstein E, Walker MD. The promoter of the pri-miR-375 gene directs expression selectively to the endocrine pancreas. PLoS One 2009, 4(4):e5033.
28. Grandinetti KB, Spengler BA, Biedler JL, Ross RA. Loss of one HuD allele on chromosome #1p selects for amplification of the N-myc proto-oncogene in human neuroblastoma cells. Oncogene 2006, 25(5):706-712.
29. Kim JW, Zeller KI, Wang Y, Jegga AG, Aronow BJ, O'Donnell KA, Dang CV. Evaluation of myc E-box phylogenetic footprints in glycolytic genes by chromatin immunoprecipitation assays. Mol Cell Biol 2004, 24(13):5923-5936.
30. Abdelmohsen K, Hutchison ER, Lee EK, Kuwano Y, Kim MM, Masuda K, Srikantan S, Subaran SS, Marasa BS, Mattson MP, Gorospe M. miR-375 inhibits differentiation of neurites by lowering HuD levels. Mol Cell Biol 2010, 30(17):4197-4210.
31. Chu VR, Lee I. MicroRNA Target Signatures in Advanced Stage Neuroblastoma. Neuroblastoma - Present and Future 2012, Intech, Shimada H, doi:10.5772/29142.